Giant cell arteritis. Part II. Treatment
Treatment options for giant cell arteritis (GCA) and its complications are considered. GCA is treatable with glucocorticoids (GC). The data available in the literature suggest that it is necessary to hospitalize GCA patients with acute vision loss or brain ischemia to administer intravenous megadose...
Main Author: | Azamat Makhmudovich Satybaldyev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2012-12-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/447 |
Similar Items
-
Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled study
by: Luca Quartuccio, et al.
Published: (2020-01-01) -
Giant cell arteritis. Part I. Terminology, classification, clinical manifestations, diagnosis
by: Azamat Makhmudovich Satybaldyev
Published: (2012-09-01) -
Giant cell arteritis. Part III. New trends in its treatment (role of genetically engineered drugs)
by: Azamat Makhmudovich Satybaldyev
Published: (2013-03-01) -
Giant cell arteritis: a multicenter observational study in Brazil
by: Alexandre Wagner Silva de Souza, et al.
Published: (2013-01-01) -
Five-year prospective multi-center cohort study of patients with giant cell arteritis in Greece
by: Christina Tsalapaki, et al.
Published: (2018-01-01)